Valacyclovir is an antiviral medication used to treat infections caused by certain types of herpes viruses. It covers a surprisingly broad range of conditions: cold sores, genital herpes, shingles, and chickenpox. Sold under the brand name Valtrex, it’s one of the most commonly prescribed antivirals in the United States.
How Valacyclovir Works
Valacyclovir is a prodrug, meaning your body converts it into another active compound, acyclovir, before it goes to work. The conversion happens rapidly, mostly in the gut and liver, before the drug even reaches your bloodstream. Once acyclovir enters your cells, it gets activated by an enzyme that only herpes viruses produce. This is a key design feature: the drug concentrates in infected cells rather than healthy ones, which is why side effects tend to be mild.
Inside infected cells, the active drug interferes with the virus’s ability to copy its DNA. It doesn’t kill the virus outright or eliminate it from your body. Herpes viruses remain dormant in nerve cells for life. What valacyclovir does is stop the virus from replicating during an active outbreak, which shortens symptoms and reduces the chance of spreading the infection to others.
Genital Herpes
Genital herpes is the most common reason valacyclovir is prescribed, and the drug is approved for several distinct uses within this category.
For a first outbreak, which is typically the most severe, treatment lasts 7 to 10 days. First episodes often involve painful sores, flu-like symptoms, and swollen lymph nodes, and starting the medication early can significantly shorten that experience.
For recurrent outbreaks, the treatment course is shorter, usually 3 to 5 days. Many people learn to recognize the early warning signs of an outbreak (tingling, itching, or burning at the site) and begin treatment at the first hint of symptoms, which can sometimes prevent sores from developing at all.
Suppressive therapy is a different approach entirely. Instead of treating outbreaks as they happen, you take a lower dose every day to prevent them. Daily suppressive therapy reduces the frequency of outbreaks by 70% to 80% in people who experience them often. It’s also approved for people living with HIV.
Perhaps the most important use for many couples: daily valacyclovir reduces the risk of transmitting genital herpes to an uninfected partner. This makes it the only antiviral approved specifically for reducing herpes transmission, not just treating symptoms.
Cold Sores
Valacyclovir is approved to treat cold sores (herpes labialis) in adults and in children aged 12 and older. Cold sores are caused by herpes simplex virus, usually type 1, and appear as blistering sores on or around the lips.
The treatment protocol for cold sores is notably short. It’s designed as a one-day treatment: two high doses taken 12 hours apart. Timing matters. Starting at the first sign of tingling or redness, before blisters form, gives the best results. When taken early, the medication can reduce healing time by about a day compared to no treatment, and in some cases can prevent the sore from fully developing.
Shingles
Shingles is caused by the varicella-zoster virus, the same virus that causes chickenpox. After you recover from chickenpox, the virus hides in nerve tissue and can reactivate decades later as a painful, blistering rash that typically wraps around one side of the torso or face.
Valacyclovir is approved for treating shingles in adults. Treatment lasts 7 days and works best when started within 72 hours of the rash appearing. Starting treatment quickly doesn’t just shorten the outbreak. It also reduces the risk of postherpetic neuralgia, a condition where nerve pain lingers for months or even years after the rash clears. This lingering pain is the most feared complication of shingles, especially in older adults, which is why prompt treatment matters so much.
Chickenpox in Children
Valacyclovir is approved for treating chickenpox in children and adolescents aged 2 to 17. While chickenpox is usually mild in healthy children, antiviral treatment can reduce the number of lesions, shorten the duration of fever, and speed overall recovery. It’s most useful in children who are at risk for more severe disease or who are seen early in the course of illness.
Common Side Effects
Valacyclovir is generally well tolerated. The most frequently reported side effects in clinical trials were headache and nausea. In shingles studies, 14% of patients experienced headache (compared to 12% on placebo) and 15% reported nausea (compared to 8% on placebo). Abdominal pain occurred in a small percentage of patients across all study groups.
In genital herpes trials, headache rates were similar between the drug and placebo groups, suggesting that some of the headache may be related to the condition itself rather than the medication. Nausea was reported by 5% to 11% of patients depending on the dose.
One important safety consideration involves kidney function. Valacyclovir is cleared through the kidneys, and people with reduced kidney function need lower doses to avoid a buildup of the drug in the body. In rare cases, particularly in elderly patients or those with kidney disease who received doses that were too high, serious nervous system side effects have been reported, including confusion, agitation, and hallucinations. These resolve when the medication is stopped.
Use During Pregnancy and Breastfeeding
Valacyclovir is sometimes prescribed during pregnancy, particularly near the end of the third trimester, to prevent an active genital herpes outbreak during delivery. An active outbreak at the time of birth poses a serious risk of neonatal herpes, so suppressive therapy in the final weeks of pregnancy is a common strategy.
During breastfeeding, the drug is considered compatible with nursing. Valacyclovir converts to acyclovir in the body, and only very small amounts of acyclovir pass into breast milk. Because acyclovir is poorly absorbed through the gut, the amount a nursing infant would actually take in is minimal. Side effects in breastfed infants are not expected, though monitoring for drowsiness, skin rashes, or digestive changes is a reasonable precaution.
Off-Label Uses
Valacyclovir is occasionally used for conditions beyond its official approvals. One example is Bell’s palsy, a sudden paralysis of the facial nerve that may be triggered by herpes simplex virus reactivation. Some clinicians prescribe valacyclovir alongside corticosteroids for severe cases, though evidence is mixed. A large clinical trial found that adding valacyclovir to steroid treatment produced a 74% recovery rate, compared to 71% with steroids alone, a difference too small to be meaningful for most patients. Current thinking is that steroids alone are sufficient for typical cases, but antivirals may still be worth considering in severe paralysis or when herpes zoster is suspected.
Valacyclovir is also sometimes used to prevent viral infections in people with weakened immune systems, such as organ transplant recipients, though other antivirals are more commonly chosen for these situations.